Attorney General Raúl Torrez announced settlements with two major insulin manufacturers—Sanofi-Aventis U.S. LLC and Novo Nordisk Inc.—that will dramatically reduce the cost of insulin for tens of thousands of New Mexicans. The agreements represent a major step toward ensuring affordable, equitable access to life-saving medication for individuals managing diabetes. “These are huge wins for New Mexicans who have struggled with the outrageous cost of insulin. These agreements will help people stop rationing medication, avoid financial hardship, and focus on staying healthy. We are holding drug manufacturers accountable and making access to life-saving treatment more equitable.” – AG Torrez